Global Female Infertility Drugs Market Growth (Status and Outlook) 2022-2028
- LP 4919353
- 89 Pages
- March 2022
- Pharmaceuticals
The United States Female Infertility Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Female Infertility Drugs market, reaching US$ million by the year 2028. As for the Europe Female Infertility Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Female Infertility Drugs players cover Allergan Plc, Ferring BV, Merck KGaA, and Novartis AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Female Infertility Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Parenteral
Oral
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Ovarian Hyperstimulation Syndrome
Multiple-gestation Pregnancies
Multiple-birth Infants
Premature Labor
Low Birth Weight
Risk of Cesarean Delivery
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Allergan Plc
Ferring BV
Merck KGaA
Novartis AG
Sanofi
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Female Infertility Drugs Market Size 2017-2028
2.1.2 Female Infertility Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Female Infertility Drugs Segment by Type
2.2.1 Parenteral
2.2.2 Oral
2.2.3 Others
2.3 Female Infertility Drugs Market Size by Type
2.3.1 Female Infertility Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Female Infertility Drugs Market Size Market Share by Type (2017-2022)
2.4 Female Infertility Drugs Segment by Application
2.4.1 Ovarian Hyperstimulation Syndrome
2.4.2 Multiple-gestation Pregnancies
2.4.3 Multiple-birth Infants
2.4.4 Premature Labor
2.4.5 Low Birth Weight
2.4.6 Risk of Cesarean Delivery
2.5 Female Infertility Drugs Market Size by Application
2.5.1 Female Infertility Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Female Infertility Drugs Market Size Market Share by Application (2017-2022)
3 Female Infertility Drugs Market Size by Player
3.1 Female Infertility Drugs Market Size Market Share by Players
3.1.1 Global Female Infertility Drugs Revenue by Players (2020-2022)
3.1.2 Global Female Infertility Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Female Infertility Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Female Infertility Drugs by Regions
4.1 Female Infertility Drugs Market Size by Regions (2017-2022)
4.2 Americas Female Infertility Drugs Market Size Growth (2017-2022)
4.3 APAC Female Infertility Drugs Market Size Growth (2017-2022)
4.4 Europe Female Infertility Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Female Infertility Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Female Infertility Drugs Market Size by Country (2017-2022)
5.2 Americas Female Infertility Drugs Market Size by Type (2017-2022)
5.3 Americas Female Infertility Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Female Infertility Drugs Market Size by Region (2017-2022)
6.2 APAC Female Infertility Drugs Market Size by Type (2017-2022)
6.3 APAC Female Infertility Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Female Infertility Drugs by Country (2017-2022)
7.2 Europe Female Infertility Drugs Market Size by Type (2017-2022)
7.3 Europe Female Infertility Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Female Infertility Drugs by Region (2017-2022)
8.2 Middle East & Africa Female Infertility Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Female Infertility Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Female Infertility Drugs Market Forecast
10.1 Global Female Infertility Drugs Forecast by Regions (2023-2028)
10.1.1 Global Female Infertility Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Female Infertility Drugs Forecast
10.1.3 APAC Female Infertility Drugs Forecast
10.1.4 Europe Female Infertility Drugs Forecast
10.1.5 Middle East & Africa Female Infertility Drugs Forecast
10.2 Americas Female Infertility Drugs Forecast by Country (2023-2028)
10.2.1 United States Female Infertility Drugs Market Forecast
10.2.2 Canada Female Infertility Drugs Market Forecast
10.2.3 Mexico Female Infertility Drugs Market Forecast
10.2.4 Brazil Female Infertility Drugs Market Forecast
10.3 APAC Female Infertility Drugs Forecast by Region (2023-2028)
10.3.1 China Female Infertility Drugs Market Forecast
10.3.2 Japan Female Infertility Drugs Market Forecast
10.3.3 Korea Female Infertility Drugs Market Forecast
10.3.4 Southeast Asia Female Infertility Drugs Market Forecast
10.3.5 India Female Infertility Drugs Market Forecast
10.3.6 Australia Female Infertility Drugs Market Forecast
10.4 Europe Female Infertility Drugs Forecast by Country (2023-2028)
10.4.1 Germany Female Infertility Drugs Market Forecast
10.4.2 France Female Infertility Drugs Market Forecast
10.4.3 UK Female Infertility Drugs Market Forecast
10.4.4 Italy Female Infertility Drugs Market Forecast
10.4.5 Russia Female Infertility Drugs Market Forecast
10.5 Middle East & Africa Female Infertility Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Female Infertility Drugs Market Forecast
10.5.2 South Africa Female Infertility Drugs Market Forecast
10.5.3 Israel Female Infertility Drugs Market Forecast
10.5.4 Turkey Female Infertility Drugs Market Forecast
10.5.5 GCC Countries Female Infertility Drugs Market Forecast
10.6 Global Female Infertility Drugs Forecast by Type (2023-2028)
10.7 Global Female Infertility Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Allergan Plc
11.1.1 Allergan Plc Company Information
11.1.2 Allergan Plc Female Infertility Drugs Product Offered
11.1.3 Allergan Plc Female Infertility Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Allergan Plc Main Business Overview
11.1.5 Allergan Plc Latest Developments
11.2 Ferring BV
11.2.1 Ferring BV Company Information
11.2.2 Ferring BV Female Infertility Drugs Product Offered
11.2.3 Ferring BV Female Infertility Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Ferring BV Main Business Overview
11.2.5 Ferring BV Latest Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Company Information
11.3.2 Merck KGaA Female Infertility Drugs Product Offered
11.3.3 Merck KGaA Female Infertility Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Merck KGaA Main Business Overview
11.3.5 Merck KGaA Latest Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Information
11.4.2 Novartis AG Female Infertility Drugs Product Offered
11.4.3 Novartis AG Female Infertility Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novartis AG Main Business Overview
11.4.5 Novartis AG Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Female Infertility Drugs Product Offered
11.5.3 Sanofi Female Infertility Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
12 Research Findings and Conclusion
Table 1. Female Infertility Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Parenteral
Table 3. Major Players of Oral
Table 4. Major Players of Others
Table 5. Female Infertility Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Female Infertility Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Female Infertility Drugs Market Size Market Share by Type (2017-2022)
Table 8. Female Infertility Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Female Infertility Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Female Infertility Drugs Market Size Market Share by Application (2017-2022)
Table 11. Global Female Infertility Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Female Infertility Drugs Revenue Market Share by Player (2020-2022)
Table 13. Female Infertility Drugs Key Players Head office and Products Offered
Table 14. Female Infertility Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Female Infertility Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Female Infertility Drugs Market Size Market Share by Regions (2017-2022)
Table 19. Americas Female Infertility Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Female Infertility Drugs Market Size Market Share by Country (2017-2022)
Table 21. Americas Female Infertility Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Female Infertility Drugs Market Size Market Share by Type (2017-2022)
Table 23. Americas Female Infertility Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Female Infertility Drugs Market Size Market Share by Application (2017-2022)
Table 25. APAC Female Infertility Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Female Infertility Drugs Market Size Market Share by Region (2017-2022)
Table 27. APAC Female Infertility Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Female Infertility Drugs Market Size Market Share by Type (2017-2022)
Table 29. APAC Female Infertility Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Female Infertility Drugs Market Size Market Share by Application (2017-2022)
Table 31. Europe Female Infertility Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Female Infertility Drugs Market Size Market Share by Country (2017-2022)
Table 33. Europe Female Infertility Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Female Infertility Drugs Market Size Market Share by Type (2017-2022)
Table 35. Europe Female Infertility Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Female Infertility Drugs Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Female Infertility Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Female Infertility Drugs Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Female Infertility Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Female Infertility Drugs Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Female Infertility Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Female Infertility Drugs Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Female Infertility Drugs
Table 44. Key Market Challenges & Risks of Female Infertility Drugs
Table 45. Key Industry Trends of Female Infertility Drugs
Table 46. Global Female Infertility Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Female Infertility Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Female Infertility Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Female Infertility Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Female Infertility Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Female Infertility Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 52. Allergan Plc Details, Company Type, Female Infertility Drugs Area Served and Its Competitors
Table 53. Allergan Plc Female Infertility Drugs Product Offered
Table 54. Allergan Plc Female Infertility Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Allergan Plc Main Business
Table 56. Allergan Plc Latest Developments
Table 57. Ferring BV Details, Company Type, Female Infertility Drugs Area Served and Its Competitors
Table 58. Ferring BV Female Infertility Drugs Product Offered
Table 59. Ferring BV Main Business
Table 60. Ferring BV Female Infertility Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Ferring BV Latest Developments
Table 62. Merck KGaA Details, Company Type, Female Infertility Drugs Area Served and Its Competitors
Table 63. Merck KGaA Female Infertility Drugs Product Offered
Table 64. Merck KGaA Main Business
Table 65. Merck KGaA Female Infertility Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Merck KGaA Latest Developments
Table 67. Novartis AG Details, Company Type, Female Infertility Drugs Area Served and Its Competitors
Table 68. Novartis AG Female Infertility Drugs Product Offered
Table 69. Novartis AG Main Business
Table 70. Novartis AG Female Infertility Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Novartis AG Latest Developments
Table 72. Sanofi Details, Company Type, Female Infertility Drugs Area Served and Its Competitors
Table 73. Sanofi Female Infertility Drugs Product Offered
Table 74. Sanofi Main Business
Table 75. Sanofi Female Infertility Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Sanofi Latest Developments
List of Figures
Figure 1. Female Infertility Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Female Infertility Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Female Infertility Drugs Market Size Market Share by Type in 2021
Figure 7. Female Infertility Drugs in Ovarian Hyperstimulation Syndrome
Figure 8. Global Female Infertility Drugs Market: Ovarian Hyperstimulation Syndrome (2017-2022) & ($ Millions)
Figure 9. Female Infertility Drugs in Multiple-gestation Pregnancies
Figure 10. Global Female Infertility Drugs Market: Multiple-gestation Pregnancies (2017-2022) & ($ Millions)
Figure 11. Female Infertility Drugs in Multiple-birth Infants
Figure 12. Global Female Infertility Drugs Market: Multiple-birth Infants (2017-2022) & ($ Millions)
Figure 13. Female Infertility Drugs in Premature Labor
Figure 14. Global Female Infertility Drugs Market: Premature Labor (2017-2022) & ($ Millions)
Figure 15. Female Infertility Drugs in Low Birth Weight
Figure 16. Global Female Infertility Drugs Market: Low Birth Weight (2017-2022) & ($ Millions)
Figure 17. Female Infertility Drugs in Risk of Cesarean Delivery
Figure 18. Global Female Infertility Drugs Market: Risk of Cesarean Delivery (2017-2022) & ($ Millions)
Figure 19. Global Female Infertility Drugs Market Size Market Share by Application in 2021
Figure 20. Global Female Infertility Drugs Revenue Market Share by Player in 2021
Figure 21. Global Female Infertility Drugs Market Size Market Share by Regions (2017-2022)
Figure 22. Americas Female Infertility Drugs Market Size 2017-2022 ($ Millions)
Figure 23. APAC Female Infertility Drugs Market Size 2017-2022 ($ Millions)
Figure 24. Europe Female Infertility Drugs Market Size 2017-2022 ($ Millions)
Figure 25. Middle East & Africa Female Infertility Drugs Market Size 2017-2022 ($ Millions)
Figure 26. Americas Female Infertility Drugs Value Market Share by Country in 2021
Figure 27. Americas Female Infertility Drugs Consumption Market Share by Type in 2021
Figure 28. Americas Female Infertility Drugs Market Size Market Share by Application in 2021
Figure 29. United States Female Infertility Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 30. Canada Female Infertility Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 31. Mexico Female Infertility Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Brazil Female Infertility Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. APAC Female Infertility Drugs Market Size Market Share by Region in 2021
Figure 34. APAC Female Infertility Drugs Market Size Market Share by Application in 2021
Figure 35. China Female Infertility Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 36. Japan Female Infertility Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 37. Korea Female Infertility Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 38. Southeast Asia Female Infertility Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 39. India Female Infertility Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 40. Australia Female Infertility Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. Europe Female Infertility Drugs Market Size Market Share by Country in 2021
Figure 42. Europe Female Infertility Drugs Market Size Market Share by Type in 2021
Figure 43. Europe Female Infertility Drugs Market Size Market Share by Application in 2021
Figure 44. Germany Female Infertility Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 45. France Female Infertility Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 46. UK Female Infertility Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 47. Italy Female Infertility Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 48. Russia Female Infertility Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. Middle East & Africa Female Infertility Drugs Market Size Market Share by Region in 2021
Figure 50. Middle East & Africa Female Infertility Drugs Market Size Market Share by Type in 2021
Figure 51. Middle East & Africa Female Infertility Drugs Market Size Market Share by Application in 2021
Figure 52. Egypt Female Infertility Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 53. South Africa Female Infertility Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 54. Israel Female Infertility Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 55. Turkey Female Infertility Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 56. GCC Country Female Infertility Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 57. Americas Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 58. APAC Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 59. Europe Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Middle East & Africa Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 61. United States Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Canada Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 63. Mexico Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 64. Brazil Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 65. China Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 66. Japan Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 67. Korea Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 68. Southeast Asia Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 69. India Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 70. Australia Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Germany Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 72. France Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 73. UK Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 74. Italy Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 75. Russia Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 76. Spain Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 77. Egypt Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 78. South Africa Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 79. Israel Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 80. Turkey Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Figure 81. GCC Countries Female Infertility Drugs Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
